Loading...

Immunotherapy for head and neck squamous cell carcinoma

Over the past years immuno-oncology has evolved and become a novel promising strategy for cancer therapy. Immune checkpoint inhibitors such as pembrolizumab or nivolumab, which target the interaction between programmed death receptor 1/programmed death ligand 1 (PD-1/PDL-1) and PDL-2, have been rece...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Memo
Hovedforfatter: Fuereder, Thorsten
Format: Artigo
Sprog:Inglês
Udgivet: Springer Vienna 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4923082/
https://ncbi.nlm.nih.gov/pubmed/27429658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12254-016-0270-8
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!